Bon Natural Life Limited BON
Regular-session close
After hours · Nov 19, 6:39 PM ET
- YTD
- -33.96%
- 1 year
- -39.31%
5D -0.08 (-7.14%)
- Market cap
- 8.58M
- Revenue (ttm)
- 25.56M
- Profit margin
- 9.65%
- EPS (ttm)
- -2.79
- Shares out
- 3.97M
- Forward P/E
- 2.76
- YTD return
- -33.96%
- 1-year return
- -39.31%
- Volume
- 13.84K
- Avg volume
- 8.93K
- Open
- 1.05
- Previous close
- 1.05
- Day's range
- 1.00 – 1.07
- 52-week range
- 0.95 – 1.94
- Beta
- -1.18
- 50-day average
- 1.52
Key statistics
- 200-day average
- 2.37
- Enterprise value
- 8.64M
- Price / sales
- 0.25
- Price / book
- 0.06
- Revenue growth
- -28.00%
- Free cash flow
- -978.17K
- Total cash
- 717.88K
- Total debt
- 6.66M
- Return on equity
- 6.61%
- Short % of float
- 0.53%
Fundamental scorecard
5 of 25 checks passed on BON’s reported financials
5of 25 checks passed
- Value 2 of 5
- Growth 0 of 5
- Profitability 0 of 5
- Financial health 3 of 5
- Dividend 0 of 5
Statements to Mar 31, 2026.
Financials — quick view
About Bon Natural Life Limited
Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. It offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. Its products are used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company was founded in 2006 and is based in Xi'an, the People's Republic of China.
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Country
- China
- Website
- bnlus.com
News
Contrasting CF Industries (NYSE:CF) & Bon Natural Life (NASDAQ:BON)
BON CHARGE launches The BON CHARGE Method, an immersive guided wellness experience led by personal trainer to the stars
BON Unveils Strategic Partnership with Tigerbone Group to Launch New Natural Health Initiatives
Analyzing Sow Good (NASDAQ:SOWG) & Bon Natural Life (NASDAQ:BON)
Head-To-Head Contrast: Bon Natural Life (NASDAQ:BON) vs. Pigeon (OTCMKTS:PGENY)
BON Announces Breakthrough Development of Apple Bio-Electronic Mask: Clinical Data Exceeds Expectations, Targeting $100B+ Medical Aesthetics Market
BON Partners with Chang'an Pilot to Launch World-Class Joint Laboratory for Natural Ingredient Bio-manufacturing
Foxx Development (NASDAQ:FOXX) & Bon Natural Life (NASDAQ:BON) Head-To-Head Contrast
Bon Natural Life Limited (NASDAQ:BON) Sees Significant Increase in Short Interest
Lifetime Brands (NASDAQ:LCUT) & Bon Natural Life (NASDAQ:BON) Head-To-Head Review
Your note
Sign in to keep a note on BON — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| UBS Group AG | 0.59% | 68,956 | 110.33K | Jun 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.01% | 440 | 704 | Sep 29, 2024 |
